Corvus Pharmaceuticals Commercial Paper Liability (Quarterly) Analysis

Corvus Pharmaceuticals, Inc. (CRVS)

18.54 +0.28 (+1.53%) USD | NASDAQ | Feb 27, 10:44

View Commercial Paper Liability (Quarterly) for CRVS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Commercial Paper Liability (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Commercial Paper Liability (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Commercial Paper Liability (Quarterly) Benchmarks

Start Trial

Regeneron Pharmaceuticals, Inc.	--
Plus Therapeutics, Inc.	--
Geron Corp.	--
Jaguar Health, Inc.	--
Krystal Biotech, Inc.	--